Banque Pictet & Cie Sa Repligen Corp Transaction History
Banque Pictet & Cie Sa
- $13.1 Billion
- Q3 2024
A detailed history of Banque Pictet & Cie Sa transactions in Repligen Corp stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 24,453 shares of RGEN stock, worth $3.33 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
24,453
Previous 34,515
29.15%
Holding current value
$3.33 Million
Previous $4.35 Million
16.34%
% of portfolio
0.03%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding RGEN
# of Institutions
490Shares Held
53.8MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$691 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$628 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$237 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$194 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.57B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....